Literature DB >> 22814322

Myxoinflammatory fibroblastic sarcoma of the face.

Cristina Gómez Martín1, María I Ortega, José A Aramburu, José L Fernández-Cañamaque.   

Abstract

Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare low-grade tumor of modified fibroblasts, with tendency to local recurrence. This unusual entity typically presents as a slow-growing painless mass in the distal extremities of middle-aged subjects. A 48-year-old woman presented to our clinic with a painless subcutaneous mass in the right temporal region. Excisional biopsy made the rare diagnosis of MIFS. Histologic examination showed the unique features that characterize this lesion: a myxoid component with a superimposed inflammatory infiltrate and the presence of distinctive, large, and bizarre Reed-Stemberg-like cells. A second wide tumor bed resection was performed, achieving clear margins. No adjuvant therapy was administered, and the patient is free of disease at 18 months postoperatively. To the best of our knowledge, this is the first reported case of MIFS presenting in the face. This adds another possibility for differential diagnoses of soft tissue tumors of the face.

Entities:  

Mesh:

Year:  2012        PMID: 22814322     DOI: 10.1097/DAD.0b013e31824e9a28

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

Review 1.  A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases.

Authors:  Raffaele Lombardi; Elio Jovine; Nicola Zanini; Maria Cristina Salone; Marco Gambarotti; Alberto Righi; Alba Balladelli; Marco Colangeli; Michele Rocca
Journal:  Int Orthop       Date:  2013-09-06       Impact factor: 3.075

2.  The first case of myxoinflammatory fibroblastic sarcoma affecting the maxillary bone.

Authors:  Çetin Boran; Asuman Kilitci; Hilal Ahsen; Fahri Yılmaz
Journal:  Int J Health Sci (Qassim)       Date:  2022 Mar-Apr

3.  Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.

Authors:  David Suster; Michael Michal; Huiya Huang; Shira Ronen; Stephanie Springborn; Maria Debiec-Rychter; Steven D Billings; John R Goldblum; Brian P Rubin; Michal Michal; Saul Suster; A Craig Mackinnon
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.